Antidote Stocking at Hospitals in North Palestine

Sawalha F, Ansam and Sweileh M, Waleed and Zyoud H, Sa'ed and Al-Jabi W, Samah (2007) Antidote Stocking at Hospitals in North Palestine. [Journal (On-line/Unpaginated)]

Full text available as:



Objective: The purpose of this study was to determine the availability and adequacy of antidote stocking at hospitals in north Palestine based on published guidelines for antidote stocking. Methodology: This study is a cross sectional survey of all hospitals at north Palestine (n=11) using a questionnaire which was completed by the director of the pharmacy department at each hospital. The questionnaire was divided into 2 parts. The first part contained a list of 25 antidotes while the second part contained a list of 12 antidotes. This classification is based on the guideline proposed by the British Association for Emergency Medicine (BAEM). The net antidote stock results were compared with the American guidelines as well. Result: The overall availability of each antidote in the first list varied widely from zero for glucagon to 100% for atropine. The number antidotes of the first list that were stocked in the 11 hospitals ranged from 5 to 12 antidotes but none of the hospitals stocked all the 25 antidotes. Additionally, availability of antidotes in the second list varied widely from zero for polyethylene glycol to 100% for dobutamine. The number of antidotes stocked ranged from 5 to 9 but none of the hospitals stocked all the 12 antidotes. Discussion and Conclusion: hospitals in north Palestine do not have adequate stock of antidotes. Raising awareness of the importance of antidotes by education, regular review of antidote storage, distribution plans, and appropriate legislation might provide solutions. Coordination between Palestinian hospitals and the PCDIC at An-Najah National University is also important.

Item Type:Journal (On-line/Unpaginated)
Keywords:Antidote, Hospital, Palestine, Stocking, Poisoning
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:5496
Deposited By: Kakkilaya Bevinje, Dr. Srinivas
Deposited On:26 Apr 2007
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Yang CC, Wu JF, Ong HC, Hung SC, Kuo YP, Sa CH, Chen SS, Deng JF. Taiwan National Poison Center: Epidemiologic data 1985–1993. J Toxicol Clin Toxicol. J Toxicol Clin Toxicol. 1996;34(6):651-63

2. Mannaioni PF. Pattern of acute intoxication in Florence: A comparative investigation. Intensive Care Med. 1991;17:S24–S31.

3. Dart RC, Stark Y, Fulton B, Koziol-Mclain J, Lowenstein SR Insufficient stocking of poison antidotes in hospital pharmacies. JAMA. 1996;276:1508–1510.

4. Litovitz TL, Felberg L, White S, Klein-Schwartz W. 1995 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med. 1996;14(5):487–537.

5. Pronczuk de Garbino J, Haines JA, Jacobsen D, Meredith T. Evaluation of antidotes: Activities of the international programme on chemical safety. J Toxicol Clin Toxicol. 1997;35(4):333–343.

6. Woolf AD, Chrisanthus K. On-site availability of selected antidotes: results of a survey of Massachusetts hospitals. Am J Emerg Med. 1997;15(1):62-66.

7. Howland MA, Weisman R, Sauter D, Goldfrank L. Nonavailability of poison antidotes [letter]. N Engl J Med. 1986;314(14):927-928.

8. Chyka PA, Connor HG. Availability of antidotes in rural and urban hospitals in Tennessee. Am J Hosp Pharm 1994;51(10):1346-1348.

9. Teresi WM, King WD. Survey of the stocking of poison antidotes in Alabama hospitals. South Med J. 1999;92 (12):1151-1156.

10. Juurlink DN, McGuigan MA, Paton TW, Redelmeier DA. Availability of antidotes in acute care hospitals in Ontario. CMAJ. 2001;165(1):27-30.

11. Bailey B, Bussieres JF. Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption. Can J Clin Pharmacol. 2000;7(4):198-204.

12. Solheim L, Andrew E, Jacobsen D. Antidote availability in Norway. Tidsskr Nor Laegeforen. 2002;122(11):1111-1113.

13. Hruby K. Availability of antidotes in hospital pharmacies in the Czech Republic. Ceska Slov Farm. 2003;52(5):231-240.

14. Hara C, Hashizume T, Tanaka J et al. Problems in hospital preparation of acute poisoning antagonist (methylene blue injection) Chudoku Kenkyu. 2006;19(3):257-263.

15. Dart RC, Goldfrank LR, Chyka PA, Lotzer D, Woolf AD, McNally J, et al. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med. 2000;36(2):126-132.

16. Guideline on antidote availability for accident and emergency department: Guy’s and St Thomas’ poison unit, Royal College of surgeons of England, British association for emergency medicine.

17. The WHO Expert Committee The use of essential drugs. Model List of Essential Drugs (ninth list). Seventh report of the WHO Expert Committee. Geneva, World Health Organization, 1997 (WHO Technical Report Series, No. 867).

18. Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, editors. Goldfrank's toxicologic emergencies. 8th ed. New York,NY. McGraw-Hill; 2006.

19. Betten DP, Vohra RB, Cook MD, Matteucci MJ, Clark RF. Antidote use in the critically ill poisoned patient. J Intensive Care Med. 2006;21(5):255-277.

20. Bowden CA, Krenzelok EP. Clinical Applications of commonly used contemporary antidotes: A US perspective. Drug Safety 1997;16(1):9–47.

21. Hall AH, Kulig KW, Rumack BH. Drug- and chemical-induced methaemoglobinemia: Clinical features and management. Med Toxicol 1986;1(4):253–260.

22. Tafuri J. Roberts J. Organophosphate poisoning. Ann Emerg Med 1987; 16(2):193–202.

23. Sivilotti MLA, Eisen JS, Lee JS, Peterson RG. Can emergency departments not afford to carry essential antidotes? CJEM 2002;4(1):23-33.

24. Burda AM. Poison antidotes: issues of inadequate stocking with review of uses of 24 common antidotal agents. J Pharm Prac 1997;10(4):235-248.

25. Kanatani, M S, Kearney, T S, Levin, R H et al., Treatment of toxicologic emergencies – antidote preparedness [abstract]. Vet Hum Toxicol 1992;34:319.

26. Parker DP, Dart RC, McNally JT. Critical deficiencies in the treatment of toxicologic emergencies: Antidote stocking in Arizona hospitals [abstract]. Vet Hum Toxicol 1990;32:376.


Repository Staff Only: item control page